- Home
- CLGN vs ZGM Comparison
CLGN vs ZGM Comparison
Compare CLGN & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- ZGM
- Stock Information
- Founded
- CLGN 2004
- ZGM 2019
- Country
- CLGN Israel
- ZGM Macau
- Employees
- CLGN N/A
- ZGM N/A
- Industry
- CLGN Industrial Specialties
- ZGM Professional Services
- Sector
- CLGN Health Care
- ZGM Consumer Discretionary
- Exchange
- CLGN Nasdaq
- ZGM Nasdaq
- Market Cap
- CLGN 33.8M
- ZGM 30.0M
- IPO Year
- CLGN N/A
- ZGM 2025
- Fundamental
- Price
- CLGN $2.11
- ZGM $2.50
- Analyst Decision
- CLGN Strong Buy
- ZGM
- Analyst Count
- CLGN 2
- ZGM 0
- Target Price
- CLGN $11.50
- ZGM N/A
- AVG Volume (30 Days)
- CLGN 20.8K
- ZGM 49.2K
- Earning Date
- CLGN 11-26-2025
- ZGM 01-06-2026
- Dividend Yield
- CLGN N/A
- ZGM N/A
- EPS Growth
- CLGN N/A
- ZGM 401.52
- EPS
- CLGN N/A
- ZGM 0.17
- Revenue
- CLGN $2,475,000.00
- ZGM $3,620,780.00
- Revenue This Year
- CLGN $1,617.28
- ZGM N/A
- Revenue Next Year
- CLGN $83.54
- ZGM N/A
- P/E Ratio
- CLGN N/A
- ZGM $13.92
- Revenue Growth
- CLGN 280.77
- ZGM 211.78
- 52 Week Low
- CLGN $1.31
- ZGM $1.90
- 52 Week High
- CLGN $4.98
- ZGM $4.51
- Technical
- Relative Strength Index (RSI)
- CLGN 52.69
- ZGM N/A
- Support Level
- CLGN $1.96
- ZGM N/A
- Resistance Level
- CLGN $2.24
- ZGM N/A
- Average True Range (ATR)
- CLGN 0.15
- ZGM 0.00
- MACD
- CLGN 0.03
- ZGM 0.00
- Stochastic Oscillator
- CLGN 95.00
- ZGM 0.00
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.